Accession Number:

ADB161569

Title:

Production and Characterization of an Avian Ricin Antitoxin

Descriptive Note:

Final rept. 15 Jul 1991-15 Jan 1992 on Phase 1

Corporate Author:

OPHIDIAN PHARMACEUTICALS INC MADISON WI

Personal Author(s):

Report Date:

1992-01-15

Pagination or Media Count:

24.0

Abstract:

This study was designed to demonstrate the feasibility of producing a ricin antitoxin consisting of highly purified specific avian antibodies. Antitoxins consisting of avian antibodies have significant advantages when compared to conventional mammalian e.g., horse antibodies a avian antibodies do not fix human complement, eliminating the associated risk of inflammatory reactions, and, b avian antibodies can be manufactured more economically. This study also utilized affinity chromatography to increase antibody purity, increasing effectiveness and reducing the risk of serum sickness in the patient. Ricin toxoid produced by formalin treatment was injected into laying hens followed by collection of eggs bearing hyperimmune antibody. Antibody was extracted from the yolks and assayed by enzyme immunoassay. When suitable antibody was measured in the eggs, extracted immunoglobulin was further purified by affinity chromatography using immobilized ricin.

Subject Categories:

  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE